A single cryoballoon ablation procedure results in high acute and medium-term efficacy rates for paroxysmal atrial fibrillation and lower success rates when used as stand-alone therapy for persistent ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. MUNICH — Treatment of persistent atrial fibrillation ...

In patients with atrial fibrillation (A-fib), cryoballoon treatment offers long-term outcomes that rival those of radiofrequency ablation. The findings were published online November 28, 2012, ahead ...

Atrial fibrillation, a rapid and irregular heartbeat, is putting a growing number of Americans at risk of heart failure and stroke, and in turn dramatically increasing the clinical and financial ...

AF, the most common sustained atrial arrhythmia, is more common in men where the prevalence increases with increasing age. [1] AF can be paroxysmal (episodes terminate in less than seven days), ...

Editor's Note: A previous version of this press release incorrectly reported the rate of recurrence or subsequent treatment for atrial fibrillation for the two devices in this study at 64.1 percent ...

TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution ...

If one is going to write about procedural complications for the treatment of atrial fibrillation, it is imperative to begin with givens: First, the only guaranteed way to avoid complications is to ...

The VersaCross™ Transseptal Solution is available in Pigtail and J-tip RF wire configurations. (CNW Group/Baylis Medical Company Inc.) TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced ...

The first cryoballoon cases were performed by Dr. Dan Musat, cardiac electrophysiologist at The Valley Hospital in Ridgewood, New Jersey, US. "Balloon ablation cases have an added layer of complexity ...